Federal health panel recommends resuming use of Johnson & Johnson’s COVID-19 vaccine, despite rare blood clot risk
US health advisers on Friday urged resuming COVID-19 vaccinations with Johnson & Johnson’s single-dose shot, saying its benefits outweigh a rare risk of blood clots.
1,452 confirmed cases, 13 deaths, and 106,038 vaccinations: See today’s new COVID-19 data from Mass.
The state said 30,262 people were estimated to have active cases of the potentially deadly virus, and 644 confirmed coronavirus patients were in the hospital.
Support Real Journalism
Subscribe to the Globe for just 99 cents